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In Spain, human bocavirus (HBoV) was detected in 48
(9.1%) of 527 children with gastroenteritis at similar fre-
quency as for children with respiratory illness (40/520,
7.7%). Fecal excretion adds new concern about the trans-
mission of HBoV. To our knowledge, this report is the first
to document HBoV in human feces.
H
uman bocavirus (HBoV), a recently described new
virus species belonging to the Parvoviridae family,
was identified as a human pathogen in September 2005
(1). Since then, this parvovirus has been found in children
with respiratory tract illness in practically all areas of the
world in which it has been investigated (2–5), an indica-
tion of its wide dissemination.
The Study
To determine the prevalence and clinical characteris-
tics of HBoV, we investigated the presence of this virus in
children with respiratory tract infection in our region
(Gipúzkoa, Basque Country, Spain). Among the first
patients in whom HBoV was detected in nasopharyngeal
aspirates, we found two 12-month-old children with diar-
rhea in addition to respiratory symptoms. Because animal
parvoviruses are frequently associated with enteritis in
young animals (6), we investigated the presence of HBoV
in the diarrheal feces of both children. HBoV was detected
in both samples, and no other intestinal pathogens were
identified. To rule out the possibility that this result could
have been due to fecal contamination resulting from swal-
lowing respiratory secretions, and to determine whether
the gastrointestinal tract is affected by this new respiratory
virus, we studied its presence in patient feces in 527
episodes of acute gastroenteritis, unrelated to respiratory
infection, in children <3 years of age, mainly from nonhos-
pital centers (ambulatory clinics). Our analyses were con-
ducted from December 2005 through March 2006. 
Viral DNAand RNAwere obtained from nasopharyn-
geal aspirates and stool specimens with an automatic
extractor BioRobot M48 (QIAGEN, Hilden, Germany) by
using the MagAttract Virus Mini M48 kit (QIAGEN).
cDNA was obtained by using M-MuLV reverse transcrip-
tase (Promega, Madison, WI, USA) and random primers.
Aliquots of the DNAand cDNAwere frozen at −40°C until
PCR for HBoV detection was performed. Respiratory sam-
ples were investigated for respiratory syncytial virus,
influenza viruses A and B, parainfluenza virus types 1–4,
and adenovirus by cell culture and PCR. Rhinovirus, coro-
navirus (NL63 coronavirus included), and metapneu-
movirus were studied by PCR alone. Fecal specimens were
examined for Shigella spp., Salmonella spp., Yersinia ente-
rocolitica,  Campylobacter spp., and enteroinvasive
Escherichia coli O157 by standard culture methods.
Rotavirus was investigated by enzyme immunoassay and
norovirus by reverse transcriptase PCR. HBoV detection
was performed by PCR with primers derived from the NP1
gene (1). Positive samples were retested and confirmed as
positive by using a second PCR assay with primers derived
from another location in the HBoV genome (VP1 gene)
(7). Amplified NP1 and VP1 gene fragments (354 bp and
403 bp, respectively) were sequenced and analyzed by
using the BLAST software (www.ncbi.nlm.nih.gov/
BLAST). Each PCR run included a negative control
(water) that was treated as the clinical sample throughout,
and PCR was performed with the usual precautions to
avoid contamination. Strain Spain001 (GenBank accession
no. EF186830) was included as positive control in each
PCR run.
Conclusions
Of the 527 stool samples analyzed from December
2005 through March 2006, HBoV was detected in 48
(9.1%). From a second group of 520 children <3 years of
age who came to the pediatric emergency unit of our hos-
pital with an episode of acute respiratory infection during
the same period, a similar frequency of HBoV detection
was obtained (40/520, 7.7%) when nasopharyngeal aspi-
rates were tested. Analysis of NP1 and VP1 partial gene
sequences obtained from all fecal and respiratory HBoV-
positive samples showed a similarity of >95% with previ-
ously published HBoV sequences.
Of 40 HBoV-positive respiratory samples, 25 (62.5%)
showed coinfection with other viruses (respiratory syncy-
tial virus in 13, rhinovirus in 3, influenza A in 3, coron-
avirus OC43 in 2, adenovirus in 1, influenza B in 1,
respiratory syncytial virus and coronavirus OC43 in 1, and
influenza A and rhinovirus in 1). Of the 48 HBoV-positive
fecal samples, 28 (58.3%) showed coinfection with anoth-
er intestinal pathogen (Salmonella enteritidis in 1,
Campylobacter jejuni in 5, rotavirus in 14, norovirus in 7,
and C. jejuni and norovirus in 1).
In this study, simultaneous detection of HBoV and
other agents was frequent for respiratory or enteric speci-
mens. The incidence of coinfection in respiratory illness
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was similar to that observed in studies that were not limit-
ed to specimens that had already tested negative for other
microorganisms and in which a wide number of agents
were investigated (4). Adenoviruses have been associated
with infection of the colon and the gut and are a cause of
severe gastroenteritis in nonindustrialized countries. In this
study, coinfection of adenovirus and HBoV was detected
in 1 respiratory specimen but these viruses together were
not detected in any fecal sample.
HBoV and parvovirus B19 are the only 2 species of
the Parvoviridae family that have been associated with
disease in humans. To date, HBoV has only been detected
in samples from the respiratory tract and has been associ-
ated with both upper and lower respiratory tract disease in
infants and young children. The results of our study show
that HBoV is also present in the gastrointestinal tract in
children with gastroenteritis with or without symptoms of
respiratory infection. The fecal excretion adds new con-
cern about the transmission of HBoV.
To our knowledge, this report is the first to document
HBoV in human feces. The high frequency of HBoV
detection in the feces of children with gastroenteritis and
the absence of any other intestinal pathogen suggest that
this new virus species is an enteric, as well as a respirato-
ry, pathogen. Further investigations to confirm this prelim-
inary hypothesis and gain greater knowledge of the
association between HBoV and enteric disease are
required.
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Human Bocavirus and Gastroenteritis
Bocavirus
Genus in the family Parvoviridae. Previously identi-
fied members of this genus are pathogens of bovines
and canines. A parvovirus of human origin was
recently discovered and called human bocavirus
because it is closely related to bovine parvovirus and
canine minute virus. Human bocavirus is associated
with respiratory tract infections, particularly in infants
and young children. 
Sources: Allander T, Tammi MT, Eriksson M, Bjerkner A, Tivelung-
Lindell A, Andersson B. Cloning of a human parvovirus by molecular
screening of respiratory tract samples. Proc Natl Acad Sci U S A.
2005;102:12891-6.
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